4.7 Article

V beta 18.1(+) and V alpha 2.3(+) T-cell subsets are associated with house dust mite allergy in human subjects

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 109, Issue 3, Pages 517-523

Publisher

MOSBY-ELSEVIER
DOI: 10.1067/mai.2002.121945

Keywords

T-cell receptors; allergy; T lymphocytes; flow cytometry

Ask authors/readers for more resources

Background: The recognition of allergenic peptides by T cells through their T-cell receptor (TCR) represents a crucial step in the initiation of an allergen-specific immune response. In parallel to the superantigen-driven restricted expansion of Vbeta subsets in autoimmune and infectious diseases, reports in animals and human subjects have shown a similar capacity of classical antigens. Objective: The study was performed to analyze the Valpha/Vbeta expression in house dust mite (HDM) allergy. Methods: The TCR repertoire of 15 subjects with HDM allergy, 22 atopic subjects without HDM allergy, and 19 nonatopic individuals, members of 2 extended and 4 nuclear families, was determined. By using flow cytometry, the expression of 22 Vbeta and 3 Valpha elements was analyzed in vivo and after in vitro allergen stimulation. Results: In comparison with nonatopic and atopic individuals without HDM allergy, freshly isolated PBMCs of individuals with HDM allergy showed a significantly higher frequency of Vbeta18(+) and Valpha2.3(+) T cells. Although members of all 3 groups had a similar lymphocyte proliferation response after in vitro stimulation with Der p 1 or Der p 1 peptide(101-131), a significant expansion of Vbeta18(+) and Va2.3+ T cells in vitro occurred only in individuals with HDM allergy. Moreover, the degree of expansion correlated with the levels of allergen-specific IgE antibodies. No expansion of Vbeta18(+) and Valpha2.3(+) was observed after mitogen stimulation with PHA, indicating allergen specificity of the response. Conclusion: Our results strongly suggest restricted TCR Valpha/Vbeta gene use in HDM allergy and might be a step toward TCR-based immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available